Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  AbbVie Inc    ABBV

ABBVIE INC (ABBV)

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/11/2017 01/12/2017 01/13/2017 01/17/2017 01/18/2017 Date
61.14(c) 61.28(c) 61.99(c) 61.86(c) 61.66(c) Last
13 565 179 8 194 353 7 295 072 8 446 663 5 512 707 Volume
-4.57% +0.23% +1.16% -0.21% -0.32% Change
More quotes
Financials ($)
Sales 2016 25 711 M
EBIT 2016 10 775 M
Net income 2016 6 752 M
Debt 2016 27 111 M
Yield 2016 3,69%
Sales 2017 28 251 M
EBIT 2017 12 195 M
Net income 2017 8 059 M
Debt 2017 25 106 M
Yield 2017 4,16%
P/E ratio 2016 16,19
P/E ratio 2017 12,83
EV / Sales2016 4,96x
EV / Sales2017 4,45x
Capitalization 100 529 M
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company.It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products.The company's focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and... 
Sector
Pharmaceuticals
Calendar
01/27 | 01:00pmEarnings Release
More about the company
Surperformance© ratings of AbbVie Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE INC
01/15 ABBVIE : concludes training program for pharmacy students
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12 ABBVIE : concludes training for KSU pharmacy students
01/11 ABBVIE : ex-dividend day
01/10 ABBVIE : to Host Fourth-Quarter 2016 Earnings Conference Call
01/10 EMERGENT TECHNOLOGIES’ PURE MH : Abbv)
01/10 Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal
01/09 ABBVIE : Pure MHC to Partner with AbbVie on Oncology Research
01/09 ABBVIE : Genomics Medicine Ireland and WuXi NextCODE Announce Landmark Populatio..
01/09 ABBVIE : Announces Four New Global Research Collaborations Focused on Advancing ..
More news
Sector news : Specialty & Advanced Pharmaceuticals
01:40pDJELI LILLY AND : to Buy Migraine Drug Developer CoLucid Pharmaceuticals
12:08p Drugmakers in Davos shift focus to chronic diseases of poor
08:49aDJBayer Joins Jobs Parade -- WSJ
01:56aDJBAYER : Will Keep Monsanto Jobs in U.S., Trump Team Says -- 2nd Update
12:05aDJAllergan Admits to Disclosure Violations During Valeant Bid
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on ABBVIE INC 
2015A likely recovery
More Strategies
Latest Tweets
05:00pOrphan Drugs Among 2015's Top 10 Best-Selling Medications  
03:35pBoehringer Ingelheim's marketing applications for Humira biosimilar under rev.. 
01:11pJohnson & Johnson : Technical Reports on Drug Makers Stocks -- Pfizer, Me.. 
01/17 AnaptysBio Sets Terms For $60 Million IPO $ABBV $AMGN $AZN $BLUE $CELG $GOLD.. 
01/17AnaptysBio Sets Terms For $60 Million IPO  
More tweets
Qtime:158
News from SeekingAlpha
11:27a MERGERS AND ACQUISITIONS IN 2016 : Pause For Breath In A Shifting Market
09:35a Boehringer Ingelheim's marketing applications for Humira biosimilar under rev..
01/17 AnaptysBio Sets Terms For $60 Million IPO
01/17 DGI FOR THE DIY : 2016 Portfolio Review
01/17 KaloBios - Sound Strategy Makes For An Exciting Speculative Play
Advertisement
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Technical analysis trends ABBVIE INC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 69,9 $
Spread / Average Target 13%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Azita Saleki-Gerhardt Senior Vice President-Operations
William J. Chase Chief Financial Officer & Executive Vice President
Michael E. Severino Chief Scientific Officer & Executive VP
Robert J. Alpern Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE INC-1.21%100 529
MERCK KGAA3.08%14 107
KYOWA HAKKO KIRIN CO L..-2.78%8 000
JAZZ PHARMACEUTICALS P..6.00%6 922
MALLINCKRODT PLC-0.80%5 232
ZHANGZHOU PIENTZEHUANG..-0.68%3 983
More Results